Cerus (CERS) Return on Capital Employed Growth (1y) (2012 - 2026)
Cerus (CERS) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 252.00 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -110.00 |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -231.00 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 328.00 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 658.00 |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 200.00 |
| 10 | Cerus | 496.03 Mn | 416.34 Mn | 27.89 Mn | 625.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 625.00 |
| Dec 31, 2025 | 343.00 |
| Sep 30, 2025 | 131.00 |
| Jun 30, 2025 | 275.00 |
| Mar 31, 2025 | 852.00 |
| Dec 31, 2024 | 1,157.00 |
| Sep 30, 2024 | 406.00 |
| Jun 30, 2024 | 189.00 |
| Mar 31, 2024 | -785.00 |
| Dec 31, 2023 | -1,346.00 |
| Sep 30, 2023 | 1,280.00 |
| Jun 30, 2023 | 1,091.00 |
| Mar 31, 2023 | 1,628.00 |
| Dec 31, 2022 | 2,378.00 |
| Sep 30, 2022 | -1,901.00 |
| Jun 30, 2022 | -1,630.00 |
| Mar 31, 2022 | -1,781.00 |
| Dec 31, 2021 | -2,475.00 |
| Mar 31, 2021 | 164.00 |
| Dec 31, 2020 | 505.00 |